AT1 — Atomo Diagnostics Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro CapNeutral
- AU$11.99m
- AU$5.77m
- AU$2.54m
- 23
- 45
- 27
- 24
Annual cashflow statement for Atomo Diagnostics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 0.022 | -0.862 | 0.091 | 0.005 | 0.074 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -1.84 | -6.26 | -4.23 | -2.81 | -5.85 |
Capital Expenditures | -0.813 | -1.99 | -5.9 | -2.31 | -0.401 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Cash from Investing Activities | -0.813 | -1.99 | -5.9 | -2.31 | -0.401 |
Financing Cash Flow Items | -0.008 | — | — | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 2.43 | 33.6 | 0.997 | 0.018 | -0.171 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.138 | 25.2 | -9.16 | -4.98 | -6.5 |